Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

DSpace Repository

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

Author: Hecht, J. R.; Raman, S. S.; Chan, A.; Kalinsky, K.; Baurain, J. -F.; Jimenez, M. M.; Garcia, M. M.; Berger, M. D.; Lauer, U. M.; Khattak, A.; Carrato, A.; Zhang, Y.; Liu, K.; Cha, E.; Keegan, A.; Bhatta, S.; Strassburg, C. P.; Roohullah, A.
Tübinger Autor(en):
Lauer, Ulrich Manfred
Published in: Esmo Open (2023), Bd. 8 (2), Article 100884
Verlagsangabe: Amsterdam : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.esmoop.2023.100884
ISSN: 2059-7029
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)